Categories: All postsAnalysts

Buy Descartes Systems on the pullback, Haywood Securities says

With the broader downturn across the tech sector, Descartes Systems Group (Descartes Systems Stock Quote, Chart: TSX:DSG, NASDAQ:DSGX) is now looking cheap, says Pardeep S. Sangha, analyst for Haywood Securities, who sees a projected 36 per cent upside over the next 12 months.

Ahead of Descartes’ third quarter fiscal 2019 financials due on November 28, Sangha is expecting 13 per cent year-over-year revenue growth to $70.3 million with Adj. EBITDA of $24.7 million versus $20.6 million last Q3. The analyst notes in a client update on Wednesday that he’s expecting Adj. EBITDA margins of 35.1 per cent, which would be an improvement over the 33.2 per cent margins last year.

“We like Descartes as a long-term investment opportunity because the company has high EBITDA margins, high recurring revenue, predictable cashflows, strong balance sheet, experienced management team and a track record of delivering consistently solid results. Management has followed a disciplined acquisition strategy that has resulted in a healthy share price appreciation over the past ten years,” says Sangha.

DSG is now down 23 per cent from its late August high, with Sangha saying the decline is a buying opportunity. For future catalysts, Sangha points to fourth quarter integration of recent acquisitions Velocity Mail and PinPoint, additional synergistic acquisitions over fiscal 2019, DSG reporting quarterly results above baseline calibration and EBITDA margin improvement over fiscal 2019 and 2020.

Sangha has a “Buy” rating with a US$37.25 target price for DSG

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: dsg
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Is Peloton Stock a Buy? (May, 2024)

Following news of a restructuring, Roth MKM analyst George Kelly has chopped his price target on Peloton (Peloton Stock Quote,… [Read More]

1 day ago

Is Ascend Wellness stock a buy?

Ahead of the company's first quarter results, Beacon analyst Russell Stanley thinks Ascend Wellness (Ascend Wellness Stock Quote, Chart, News,… [Read More]

1 day ago

Paradigm chops price target on Snipp Interactive

Following the company's fourth quarter results, Paradigm Capital analyst Daniel Rosenberg has cut his price target on Snipp Interactive (Snipp… [Read More]

1 day ago

It’s time to buy cannabis stocks, this analyst says

A major development came down the pipe this week at the U.S. Drug Enforcement Agency has reportedly decided to reschedule… [Read More]

2 days ago

Is Generac stock a buy?

Following the company's first quarter results, Roth MKM analyst Chip Moore remains neutral on Generac Holdings (Generac Holdings Stock Quote,… [Read More]

2 days ago

Bombardier is a buy, Desjardins says (May, 2024)

The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]

3 days ago